Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 4Spondylarthropathies 1Spondylarthritis 1Inflammatory Bowel Diseases 1Infections 1Cardiovascular Diseases 1

Interventions

Etanercept 12Adalimumab 12Infliximab 7golimumab 4Tumor Necrosis Factor Inhibitors 4Certolizumab Pegol 4Abatacept 4tofacitinib 2tocilizumab 2Rituximab 2Antirheumatic Agents 2Vitamin D 1Vaccines 1Syringes 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Saline Solution 1Radioimmunodetection 1Prednisone 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Nivolumab 1Methotrexate 1Methods 1Lysine Acetyltransferase 5 1Licensure 1Leflunomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Arthritis, Rheumatoid × Tumor Necrosis Factor Inhibitors × Clear all
NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

NCT04529902 2021-11-23

DREAM

Brigham and Women's Hospital

Completed
63,013 enrolled

Arthritis, Rheumatoid

NCT01548768 2020-11-27

RHYTHM

Columbia University

Phase 4 Completed
149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡